Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C and HIV Coinfection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03401697
What this trial is testing

Eliminating Hepatitis C Virus

Who this might be right for
Hepatitis CHIVType2 Diabetes
Icahn School of Medicine at Mount Sinai 52
Testing effectiveness (Phase 2)Study completedNCT02480387
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 HCV and HIV-1 Co-infection

Who this might be right for
Treatment of Hepatitis C
Peter J. Ruane, M.D., Inc. 20
Early research (Phase 1)Study completedNCT00545558
What this trial is testing

Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV

Who this might be right for
Hepatitis CHIV Infections
University of Cincinnati 18
Testing effectiveness (Phase 2)Study completedNCT01231685
What this trial is testing

Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection

Who this might be right for
HIVHepatitis CLiver Fibrosis
McGill University Health Centre/Research Institute of the McGill University Health Centre 9
Testing effectiveness (Phase 2)Study completedNCT00059358
What this trial is testing

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 16
Post-approval studies (Phase 4)Study completedNCT00356486
What this trial is testing

Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 74
Post-approval studies (Phase 4)Ended earlyNCT01443923
What this trial is testing

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Who this might be right for
HepatitisHIV/AIDS
National Institute of Allergy and Infectious Diseases (NIAID) 4
Testing effectiveness (Phase 2)Study completedNCT00031343
What this trial is testing

The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 128
Not applicableStudy completedNCT04652804
What this trial is testing

Supporting Treatment Outcomes Among PWID

Who this might be right for
Hepatitis CHIV Coinfection
Johns Hopkins University 3,000
Not applicableStudy completedNCT00703560
What this trial is testing

Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients

Who this might be right for
Hepatitis C
University of Texas Southwestern Medical Center 72
Not applicableEnded earlyNCT00164060
What this trial is testing

Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection

Who this might be right for
Hepatitis CHIV Infections
Bayside Health 158
Not applicableStudy completedNCT00015652
What this trial is testing

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT00879047
What this trial is testing

Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection

Who this might be right for
HIV InfectionsHepatitis C
University of California, San Francisco 30
Post-approval studies (Phase 4)Study completedNCT00866021
What this trial is testing

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

Who this might be right for
HIV/HCV Co-infectionHIV Infections
Fundacion SEIMC-GESIDA 68
Post-approval studies (Phase 4)Ended earlyNCT00742326
What this trial is testing

Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections

Who this might be right for
HIVHepatitis CLiver Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 13
Not applicableStudy completedNCT01296529
What this trial is testing

Study on Immunopathogenesis in HIV and Hepatitis C Coinfection

Who this might be right for
HIV InfectionHepatitis C InfectionFibrosis+1 more
Rush University Medical Center 59
Not applicableStudy completedNCT00150904
What this trial is testing

Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)

Who this might be right for
Hepatitis CHIV Infections
UMC Utrecht 28
Large-scale testing (Phase 3)Study completedNCT02472886
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 153
Post-approval studies (Phase 4)Study completedNCT01925183
What this trial is testing

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

Who this might be right for
Hepatitis C, ChronicHIV
Markus Peck-Radosavljevic 6
Large-scale testing (Phase 3)Study completedNCT02073656
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

Who this might be right for
Hepatitis C VirusHIV
Gilead Sciences 335
Next Page